In Vitro Antiplasmodial, Cytotoxicity, and Antioxidant Activities of Lophira lanceolata (Ochnaceae): A Cameroonian Plant Commonly Used to Treat Malaria
- PMID: 36820149
- PMCID: PMC9938790
- DOI: 10.1155/2023/4061592
In Vitro Antiplasmodial, Cytotoxicity, and Antioxidant Activities of Lophira lanceolata (Ochnaceae): A Cameroonian Plant Commonly Used to Treat Malaria
Abstract
Background: Malaria is the leading cause of morbidity and mortality in African countries. We aimed this study at evaluating the in vitro antiplasmodial, antioxidant, and cytotoxicity activity of Lophira lanceolata extracts.
Method: The aqueous and ethanol extracts were obtained by maceration. It tested in vitro the extracts against Plasmodium falciparum 3D7 and multiresistance Dd2. Macrophage cell lines (RAW 264.7 cells) and red blood cells were used for cytotoxicity tests. The antioxidant activity was assessed by 1,1-diphenyl-2-picrylhydrazine (DPPH), hydrogen peroxide (H2O2), nitric oxide (NO) reduction, and ferric reducing antioxidant power (FRAP) scavenging.
Results: The in vitro antiplasmodial results showed that the ethanol extract was the most active, with IC50 of 24.51 ± 4.77 µg/mL and 31.86 ± 3.10 µg/mL, respectively, on the resistant Dd2 and sensitive 3D7 strains unlike the aqueous which indicated moderate activity with an IC50 of 51.36 ± 4.86 μg/mL and 56.36 ± 4.27 μg/mL, respectively, on the resistant Dd2 and sensitive (3D7) strains. However, the ethanol extract had the highest activity, with an IC50 of 8.153 g/mL, 1915 g/mL, 30.81 g/mL, and 54.66 g/mL, respectively, for DPPH, H2O2, NO, and FRAP, while the aqueous extract had an IC50 of 6.724, 2387681, 185.7, and 152.0 g/mL, respectively, for DPPH, H2O2, NO, and FRAP. The cytotoxicity test reveals that both extracts do not promote red blood cell haemolysis. They presented weak activity against RAW 264.7 cells and red blood cells.
Conclusion: According to these findings, the aqueous and ethanol extracts have antiplasmodial and antioxidant activity but with no cytotoxic effects on red blood cells or RAW cells. However, it will be important to investigate the in vivo antiplasmodial and antioxidant activity of these extracts.
Copyright © 2023 Mounvera Abdel Azizi et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures







References
-
- Organization W. H. Malaria Eradication: Benefits, Future Scenarios and Feasibility: A Report of the Strategic Advisory Group on Malaria Eradication . Geneva, Switzerland: World Health Organization; 2020.
-
- Caulfield L. E., Richard S. A., Black R. E. Undernutrition as an underlying cause of malaria morbidity and mortality in children less than five years old. The American Journal of Tropical Medicine and Hygiene . 2004;71(2) - PubMed
-
- Weiss D. J., Bertozzi-Villa A., Rumisha S. F., et al. Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis. The Lancet Infectious Diseases . 2021;21(1):59–69. doi: 10.1016/s1473-3099(20)30700-3. - DOI - PMC - PubMed
-
- Malvry D. Plasmodies-Malaria. Formes Cliniques, Diagnostic . Maladies Infectieuses: Encyclopédie médico-chirurgicale; 2000.
-
- Hambaba L., Boudjellal K., Abdeddaim M., Aberkane M. C., Boudiaf K. Étude in vitro des activités antimicrobienne et antioxydante des extraits du fruit d’Elaeagnus angustifolia L. Phytothérapie . 2012;10(6):350–356. doi: 10.1007/s10298-012-0737-7. - DOI
LinkOut - more resources
Full Text Sources